div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 9button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page9jpg target=_blank amp-img class=ts-thumb alt=Page 9: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails9jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 10button div class=ts-image a href=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5page10jpg target=_blank amp-img class=ts-thumb alt=Page 10: institutovascularclinstitutovascularclwp-contentuploads201701AAA-EVAR-inicial · estudiamos 9 pacientes consecutivos portadores de AAA como posibles candidatos para esta src=https:reader042vdocumentocomreader042viewer20220227025bc3c87809d3f248318d4ef6html5thumbnails10jpg width=142 height=106 layout=responsive amp-imga divdiv